COVID-19 virus’s weekly COVID-19 news round-up

pharmafile | March 31, 2021 | News story | Research and Development COVID-19, covid 19 news, covid-19 news, covid-19 roundup 

The past week has seen plenty of positive COVID-19 news; Starpharma are to start selling their COVID-fighting nose spray in the UK, GSK & Vir’s treatment for the virus has shown an efficacy of 85% in a Phase III trial, and Johnson & Johnson are set to ship as many as 400 million vaccines to African Union countries.

1. J & J to ship up to 400 million vaccines to Africa – Published 30/03/2021

Johnson & Johnson has reached an agreement to ship as many as 400 million doses of their COVID-19 vaccine to African Union (AU) member states.

2. 500,000 Moderna COVID-19 vaccines to arrive in UK next month – Published 29/03/21

More than 500,000 doses of Moderna’s COVID-19 vaccine are set to arrive in the UK next month, ministers have confirmed.

3. GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial – Published 29/03/21

GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the treatment of COVID-19.

4. Starpharma to sell COVID-fighting nose spray in UK – Published – 25/03/21

Australian biotech company, Starpharma, has announced a deal with LloydsPharmacy to sell its COVID-fighting antiviral nasal spray, Viraleze, in the UK.  

5. AstraZeneca vaccine found to be 3% less effective after further trial analysis – Published 25/03/21

AstraZeneca have revised their findings from the US study AZD1222 of their COVID-19 vaccine, announcing a 76% efficacy against symptoms of the virus, as opposed to the 79% efficacy reported on Monday.

Jack Goddard

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …


Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content